×
ADVERTISEMENT

stem cell transplant

Many Differences in Latest HIV Patient to Achieve HIV Remission With HSCT

A 66-year-old patient living with HIV and acute myeloid leukemia achieved complete remission from both his HIV and ...

JULY 27, 2022

Speedier Busulfan Washout A Plus in HCT Conditioning?

The washout period between the last dose of metronidazole and the first dose of the alkylating agent busulfan can ...

JUNE 17, 2021

FDA: Increased Risk for Cancer Relapse With Long-Term Use of Azithromycin in Stem Cell Transplants

Results of a clinical study, which attempted to prevent this serious lung condition with azithromycin prophylaxis, ...

AUGUST 7, 2018

FDA Approves Prevymis to Prevent CMV Among Stem Cell Transplant Patients

The FDA approved Merck's Prevymis, Merck for prophylaxis of cytomegalovirus infection and disease in adult ...

NOVEMBER 9, 2017

FDA Expands Indication for Revlimid for Certain MM Patients

Celgene's Revlimid has a new indication: for MM patients following autologous hematopoietic stem cell ...

FEBRUARY 23, 2017

Load more